EUVIMEDEUVIMED entdecken
VergleichsstudieLeitlinieOpen Access · CC BY-NC-ND 4.0

Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients

Michael Dong iD, Joanna Larson, Sepideh Saroukhani iD, Miguel Escobar iD, Lakshmi Srivaths iD

Haemophilia · 2026-05 · 32 (3) · 772-778

DOI: 10.1111/hae.70275 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Haemophilia, online erschienen am 27.03.2026. Verfasst von Michael Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gulf States Hemophilia and Thrombophilia Center Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Practice Guidelines as Topic, von Willebrand Diseases, von Willebrand Factor, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biostatistics/ Epidemiology/ Research Design (BERD), Center for Clinical and Translational Sciences (CCTS), National Center for Advancing Translational Sciences (NCATS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction The 2021 ASH/ISTH/NHF/WFH VWD diagnosis guidelines recommend Type 1 VWD diagnoses for patients with (a) VWF

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Practice Guidelines as Topicvon Willebrand Diseasesvon Willebrand FactorHemorrhageAntifibrinolytic AgentsRetrospective StudiesHematologyHumansMaleFemaleInfant, NewbornInfantChild, PreschoolChildAdolescentYoung AdultAdultMiddle Aged

Stichwörter der Autor:innen

VWD guidelineslow VWFtype 1 VWD

Substanzen

von Willebrand FactorAntifibrinolytic Agents

Autor:innen und Institutionen

  • Gulf States Hemophilia and Thrombophilia Center Houston, Houston, Texas, USA.
  • Department of Pediatrics, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
  • Department of Internal Medicine, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
  • Division of Clinical and Translational Sciences, Department of Internal medicine, McGovern Medical School, and Biostatistics/Epidemiology/Research Design (BERD) component, Center For Clinical and Translational Sciences…

ORCID-Profile: Michael Dong, Sepideh Saroukhani, Miguel Escobar, Lakshmi Srivaths

Förderung

  • Biostatistics/ Epidemiology/ Research Design (BERD)
  • Center for Clinical and Translational Sciences (CCTS)
  • National Center for Advancing Translational Sciences (NCATS)

Zitieren

APA

Dong, M., Larson, J., Saroukhani, S., Escobar, M., & Srivaths, L. (2026). Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients. Haemophilia, 32(3), 772-778. https://doi.org/10.1111/hae.70275

Vancouver

Dong M, Larson J, Saroukhani S, Escobar M, Srivaths L. Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients. Haemophilia. 2026;32(3):772-778. doi:10.1111/hae.70275

BibTeX
@article{Dong2026,
  author = {Dong, Michael and Larson, Joanna and Saroukhani, Sepideh and Escobar, Miguel and Srivaths, Lakshmi},
  title = {Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients},
  journal = {Haemophilia},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {772--778},
  doi = {10.1111/hae.70275}
}
Kostenlos starten →